-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation